Long non coding mitochondrial RNAs as potential targets for diagnosis and therapy of bladder cancer

Jaime Villegas, Alexis Rivas, Rodolfo Ávila, Vincenzo Borgna, Lorena Lobos-Gonzales, Verónica Burzio, Constanza López, Reynaldo Gomez, Eduardo Landerer, Laura Velarde, L. O. Burzio

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Bladder cancer (BC) is a heterogeneous disease with 70% of patients presenting superficial tumours and 30% presenting muscle-invading disease with a high risk of death associated to metastasis. The diagnosis is carried out by urine cytology, whith high specificity but low sensitivity, and cystoscopy, an expensive and unpleasant procedure. Carcinoma in situ and other high grade non-muscle-invasive tumors are treated by intravesical administration of BCG or other chemotherapeutic agents, while the indication for muscle-invasive disease is radical cystectomy. Human cells express a family of mitochondrial long non-coding RNAs (ncRNAs). One of these transcripts, the sense mitochondrial ncRNA or SncmtRNA, is expressed in normal proliferating cells and tumor cells but not in non-dividing cells. In addition, normal human proliferating cells express two antisense transcripts, ASncmtRNA-1 and ASncmtRNA-2. Strikingly however, the ASncmtRNAs are downregulated in tumor cell lines as well as in tumor cells present in different types of human cancer, including BC. Therefore, the differential expression profile of these transcripts allows to detect cancer cells in biopsies and biological fluids. Down-regulation of the ASncmtRNAs seems to be an important hallmark of cancer and, hypothetically, may also represent a general vulnerability of cancer cells. Indeed, knock-down of the ASncmtRNAs using antisense oligonucleotides (ASO) exerts negative effects on cell proliferation and viability of bladder cancer cell lines representing a novel therapeutic strategy for this disease. We discuss recent advances on the use of the mitochondrial ncRNAs as targets for diagnostic and therapeutic protocols of BC and its potential use in the clinic.

Original languageEnglish
Title of host publicationBladder Cancer
PublisherNova Science Publishers, Inc.
Pages95-116
Number of pages22
ISBN (Electronic)9781633216709
ISBN (Print)9781633216662
Publication statusPublished - 1 Jan 2014

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Long non coding mitochondrial RNAs as potential targets for diagnosis and therapy of bladder cancer'. Together they form a unique fingerprint.

Cite this